Pediatric Phase I/II Clinical Trial on Mucopolysaccharidosis type III (MPSIIIA)
Lab support for a global pediatric trial for the rare genetic neurodegenerative…
Read more
Lab Support for the Largest Global Phase III NASH Study to Date
In a meta-analysis of several studies using various methodologies, worldwide prevalence of…
Read more
Ten-Day Study Start & Customer Test Kit Build at the Height of a Pandemic
On the upswing of the COVID-19 pandemic, an ID focused pharmaceutical client…
Read more
Retrospective Biomarker Analysis Performed To Measure Tumor-infiltrating CD39+ CD8+ T Cells in Metastatic Renal Cell Carcinoma
A biotech conducted a phase II study to analyze the percent expression…
Read more
Phase 3 Clinical Trial on the Efficacy and Safety of a New Therapy in the Treatment of Uncomplicated Influenza
Cerba Research performed a randomized, double-blind, placebo-controlled trial to evaluate the efficacy…
Read more
Phase 2c Clinical Trial on the Efficacy, Safety and Tolerability of Drug-Sensitive Smear-Positive Pulmonary Tuberculosis (DS TB) Treatment
Cerba Research performed an open-label, partially randomized trial to evaluate the efficacy,…
Read more
DIRA Assay Testing for Daratumumab Clinical Trials
Discover in this case study how a daratumumab-Specific Immunofixation Electrophoresis Reflex Assay…
Read more
Multiple Myeloma efficacy and safety of 2 different combination therapies
Discover how our team of experts performed a multicenter, randomized, open-label study…
Read more
Case Study on Multiple Myeloma
discover how our experts performed a randomised, open-label, multicentre phase 3 study…
Read more
The insights you need
Together, we can shape the future of your clinical development. Find out more about how we can support your research.